EUVIMEDEUVIMED entdecken
Crossref

PDZK1 Regulates the Stability and Function of ADRB2 to Prevent Vascular Remodelling in Hypertension

Haoran Zhang, Yan Meng, Dandan Li, Wenjing Zheng, Wenjie Bu, Zhiyu Shi, Chunnan Liu, Meng Zhao, Huiying Wang, Yufeng Bai, Liying Luo, Dechao Zhao und 1 weitere

Clinical and Experimental Pharmacology and Physiology · 2025

DOI: 10.1111/1440-1681.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2025. Verfasst von Haoran Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, Hypertension, Vascular Remodeling, Carrier Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Young Medical Talents Funding Project of the First Affiliated Hospital of Harbin Medical University, Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we found that PDZK1, a scaffold protein, interacts with the β₂‐adrenergic receptor (ADRB2) through its PDZ domains, stabilising ADRB2 by inhibiting its ubiquitination and proteasomal degradation. This study explored the PDZK1–ADRB2 interaction and its role in hypertension‐induced vascular remodelling. Using PDZK1 knockout mice infused with angiotensin II, we found that PDZK1 deficiency further exacerbates angiotensin II‐induced hypertension, vascular dysfunction, and vascular remodelling. Mechanistically, PDZK1 stabilises ADRB2 protein by preventing its ubiquitination and proteasomal degradation, thereby maintaining ADRB2‐mediated vasodilation. Additionally, PDZK1 prevents ADRB2 internalisation and its interaction with β‐arrestin, thereby inhibiting β‐arrestin–mediated ERK activation and suppressing vascular smooth muscle cell (VSMC) phenotypic switching. This mechanism contributes to vascular protection under hypertensive conditions. Targeting the PDZK1/ADRB2 interaction may provide a novel therapeutic strategy for hypertension‐related vascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, beta-2HypertensionVascular RemodelingCarrier ProteinsAnimalsMice, KnockoutMiceAngiotensin IIHumansMuscle, Smooth, VascularProtein StabilityMaleUbiquitinationMice, Inbred C57BLVasodilationbeta-Arrestins

Stichwörter der Autor:innen

ADRB2PDZK1hypertensionvascular remodellingvascular smooth muscle cells

Substanzen

Receptors, Adrenergic, beta-2Angiotensin IIADRB2 protein, mouseCarrier Proteinsbeta-Arrestins

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Heilongjiang Province Key Laboratory of Cardiovascular Disease Sound Light Electromagnetic Diagnosis and Treatment, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • The First College for Clinical Medicine, Harbin Medical University, Harbin, China.

Förderung

  • Young Medical Talents Funding Project of the First Affiliated Hospital of Harbin Medical University
  • Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province

Zitieren

APA

Zhang, H., Meng, Y., Li, D., Zheng, W., Bu, W., Shi, Z., Liu, C., Zhao, M., Wang, H., Bai, Y., Luo, L., Zhao, D., & Chi, J. (2025). PDZK1 Regulates the Stability and Function of ADRB2 to Prevent Vascular Remodelling in Hypertension. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70085

Vancouver

Zhang H, Meng Y, Li D, Zheng W, Bu W, Shi Z, et al. PDZK1 Regulates the Stability and Function of ADRB2 to Prevent Vascular Remodelling in Hypertension. Clinical and Experimental Pharmacology and Physiology. 2025. doi:10.1111/1440-1681.70085

BibTeX
@article{Zhang2025,
  author = {Zhang, Haoran and Meng, Yan and Li, Dandan and Zheng, Wenjing and Bu, Wenjie and Shi, Zhiyu and Liu, Chunnan and Zhao, Meng and Wang, Huiying and Bai, Yufeng and Luo, Liying and Zhao, Dechao and Chi, Jinyu},
  title = {PDZK1 Regulates the Stability and Function of ADRB2 to Prevent Vascular Remodelling in Hypertension},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2025},
  doi = {10.1111/1440-1681.70085}
}
Kostenlos starten →